Keith Largay joined Bain Capital’s real estate business as head of real estate capital markets, a spokesperson confirmed. It ...

According to the terms of the deal, Bain has agreed to acquire a 51 percent stake in Milacron for $287 million.

Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...

The provider of highly-engineered processing equipment and solutions will sell a 51% stake in the injection molding and extrusion business for $287 million.

Hillenbrand Inc. has announced the sale of a 51% stake in its Milacron injection molding and extrusion business to an ...

Bain Capital, a leading private investment firm, today announced a majority investment in the Milacron Injection Molding and Extrusion business (or the "Company"), a globally renowned provider of ...

Indian auto parts makers with operations in Mexico are cautiously continuing expansion plans despite US tariff uncertainties.

The head of Credit Suisse Asset Management Australia, Steve Giubin, has not ruled out forming a boutique with his small cap and/or large cap Australian equity managers, saying all options were on the ...

Brookfield made a non-binding proposal of $2.88 a share, the same value as the proposal made last month by CC Capital ...

Industry Funds Management (IFM) has won a $100-million mandate from health and community services industry superannuation fund HESTA, which wants its Australian stock investments to produce as little ...